Publication:
State of the art and future challenges in multiple sclerosis research and medical management: an insight into the 5th International Porto Congress of Multiple Sclerosis

dc.contributor.coauthorSa, Maria Jose
dc.contributor.coauthorSoares dos Reis, Ricardo
dc.contributor.coauthorCelius, Elisabeth Gulowsen
dc.contributor.coauthorChien, Claudia
dc.contributor.coauthorComi, Giancarlo
dc.contributor.coauthorGraus, Francesc
dc.contributor.coauthorHillert, Jan
dc.contributor.coauthorHobart, Jeremy
dc.contributor.coauthorKhan, Gulfaraz
dc.contributor.coauthorKissani, Najib
dc.contributor.coauthorLangdon, Dawn
dc.contributor.coauthorLeite, Maria Isabel
dc.contributor.coauthorOkuda, Darin T.
dc.contributor.coauthorPalace, Jacqueline
dc.contributor.coauthorPapais-Alvarenga, Regina Maria
dc.contributor.coauthorMendes-Pinto, Ines
dc.contributor.coauthorShi, Fu-Dong
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorAltıntaş, Ayşe
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T11:46:16Z
dc.date.issued2020
dc.description.abstractThe 5th International Porto Congress of Multiple Sclerosis took place between the 14th and 16th of February 2019 in Porto, Portugal. Its intensive programme covered a wide-range of themes-including many of the hot topics, challenges, pitfalls and yet unmet needs in the field of multiple sclerosis (MS)-led by a number of well-acknowledged world experts. This meeting review summarizes the talks that took place during the congress, which focussed on issues in MS as diverse as the development and challenges of progressive MS, epidemiology, differential diagnosis, medical management, molecular research and imaging tools.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue2
dc.description.openaccessYES
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipAlmirall
dc.description.sponsorshipBayer
dc.description.sponsorshipBiogen
dc.description.sponsorshipMerck Serono
dc.description.sponsorshipNovartis
dc.description.sponsorshipRoche
dc.description.sponsorshipSanofi Genzyme
dc.description.sponsorshipTeva
dc.description.versionPublisher version
dc.description.volume9
dc.identifier.doi10.1007/s40120-020-00202-7
dc.identifier.eissn2193-6536
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02329
dc.identifier.issn2193-8253
dc.identifier.quartileN/A
dc.identifier.scopus2-s2.0-85087974414
dc.identifier.urihttps://hdl.handle.net/20.500.14288/515
dc.identifier.wos548469600001
dc.keywordsCongress review
dc.keywordsDemyelinating diseases
dc.keywordsMultiple sclerosis
dc.keywordsNeurological diseases
dc.language.isoeng
dc.publisherSpringer
dc.relation.grantnoNA
dc.relation.ispartofNeurology and Therapy
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/8966
dc.subjectMedicine
dc.subjectClinical neurology
dc.titleState of the art and future challenges in multiple sclerosis research and medical management: an insight into the 5th International Porto Congress of Multiple Sclerosis
dc.typeReview
dspace.entity.typePublication
local.contributor.kuauthorAltıntaş, Ayşe
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery17f2dc8e-6e54-4fa8-b5e0-d6415123a93e

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
8966.pdf
Size:
454.89 KB
Format:
Adobe Portable Document Format